Meetings

Meeting Announcements

19-Mar-2026

Terasaki Institute and UCLA Technology Development Group partner to program advanced organ and tissue repair session at LABEST Innovation Conference

Terasaki Institute for Biomedical Innovation
Meeting Announcement

Los Angeles, CA. — March 19, 2026 — The Terasaki Institute for Biomedical Innovation (TIBI) and UCLA Technology Development Group (TDG) announced today a collaboration to program the Advanced Organ and Tissue Repair session during MedTech Day at LABEST, one of Southern California’s premier innovation conferences.

19-Mar-2026

European Psychiatric Association rolls out landmark action plan to modernize care and protect vulnerable mental health communities across Europe

European Psychiatric Association
Meeting Announcement

Today, the European Psychiatric Association (EPA) announces the move into full implementation of the 2026 Presidential Task Forces of its Action Plan, from protecting vulnerable groups to accelerating precision psychiatry, under President Professor Andrea Fiorillo. The Plan underpins the scientific sessions of the upcoming 34^th European Congress of Psychiatry, held 28–31 March in Prague, marking the first congress of Professor Fiorillo’s presidency.

18-Mar-2026

New ‘rock music’ is out of this world

Anglia Ruskin University
Meeting Announcement

The mysterious properties of meteorites will be transformed into music and performed live at the Cambridge Festival this Saturday (21 March). Presented by experts from Anglia Ruskin University and the University of Cambridge, the event will allow the audience to experience space science in a new way by turning the microscopic textures and mineral structures of meteorites into melodies.

18-Mar-2026

The ghost of fascism

University of Konstanz
Meeting Announcement

Is the United States under President Trump experiencing a "normal" crisis of democracy, or is a new regime taking shape? Fascism expert Sven Reichardt, a professor of contemporary history at the University of Konstanz, compares current developments with past events in the article "Can we call it fascism?" (https://www.campus.uni-konstanz.de/en/science-backstage-1/can-we-call-it-fascism) This is also the focus of the conference "Das Gespenst des Faschismus" taking place on 26 and 27 March 2026 in the Bischofsvilla in Konstanz (Germany) that is hosted by the universities of Konstanz and Münster.

17-Mar-2026

UCLA to host first Brain Health Summit, bringing together national experts to address a growing public health crisis

University of California - Los Angeles Health Sciences
Meeting Announcement

UCLA Health will host its first-ever Brain Health Summit on March 20-21, bringing together leading scientists, policymakers, philanthropists and community advocates from across the country to address one of the most pressing and underfunded challenges in public health.

17-Mar-2026

Frontiers in Science Deep Dive webinar series: Trace levels of foodborne pathogens do not always translate to health risk, says study

Frontiers
Meeting Announcement

Explore how risk-based decision-making approaches to foodborne pathogens can build healthier, more sustainable, and more resilient food systems.

16-Mar-2026

Rice hosts first-of-its-kind workshop exploring how AI can accelerate discoveries in major neutrino experiment

Rice University
Meeting Announcement

Researchers at Rice University recently convened an international group of scientists to explore how artificial intelligence and machine learning could transform one of the world’s most ambitious physics experiments: the Deep Underground Neutrino Experiment (DUNE). Held March 10-12 at Rice’s BioScience Research Collaborative, the three-day workshop brought together researchers from universities, national laboratories and international partners to discuss how the experiment’s software and computing infrastructure can better support the growing role of AI and machine learning. The event was organized by DUNE’s AI/ML Forum and Core Software and Computing Consortium and was partially supported by the Rice Creative Ventures Fund.

16-Mar-2026

Impact Journals to participate at AACR Annual Meeting 2026 in San Diego

Impact Journals LLC
Meeting Announcement

BUFFALO, NY – March 16, 2025 – Impact Journals (publisher of Aging-US, Oncotarget, Oncoscience, and Genes & Cancer), is pleased to announce its participation as an exhibitor at the American Association for Cancer Research (AACR) Annual Meeting 2026. The meeting will take place April 17–22, 2026, at the San Diego Convention Center in San Diego, CA.

13-Mar-2026

From pioneer to leader: Alex Zhavoronkov chairs precision aging discussion and presents Luminary Award to OpenAI president at PMWC 2026

InSilico Medicine
Meeting Announcement

As chair of the AI-Driven Biomarkers to Quantify Aging session, Zhavoronkov moderated a discussion on computational approaches to measuring biological age and identifying biomarkers of aging.

12-Mar-2026

VAD law experts talk dementia and critical issues at QUT conference

Queensland University of Technology
Meeting Announcement

Australia: Dementia, global trends, community attitudes, conscientious objections by doctors and health facilities, Indigenous perspectives, and organ donation are among agenda topics for the International Conference on Assisted Dying and Other End of Life Care (ICEL5) at QUT next month.

Meeting: International Conference on Assisted Dying and Other End of Life Care

12-Mar-2026

Webinar: How to communicate your science to UK policymakers

Applied Microbiology International
Meeting Announcement

Ever feel like nobody’s listening? Now’s your chance to make an impact and get your knowledge in front of decision makers.

Applied Microbiology International is offering a free webinar - part of the Sustainable Microbiology Policy Spotlight journal webinar series - that will explore how microbiologists can most effectively influence policy in the UK, with insights that apply to the international policymaking context.

11-Mar-2026

Gene therapy for Duchenne muscular dystrophy: Genethon confirms two-year efficacy in patients treated with its drug candidate GNT0004 at therapeutic dose in the first phase of its clinical trial

AFM-Téléthon
Meeting Announcement

At the 2026 MDA Conference in Orlando, Genethon unveiled new two‑year efficacy data for its gene therapy candidate GNT0004, a key milestone for Duchenne muscular dystrophy research.